This contract involves the supply of pharmaceutical products used in treatment programs for generalized myasthenia gravis, multiple sclerosis, and hepatitis C. The buyer is seeking suppliers who can provide these essential medications as part of ongoing healthcare initiatives. The total value of the
Tender closed on 5 Jun 2025. Awaiting award.
This contract opportunity involves the supply of selected laboratory tests and media, along with the leasing of analyzers, for the Microbiology Laboratory at the J. Strus Municipal Multispecialty Hospital in Poznań. Suppliers are invited to provide high-quality reagents and necessary equipment to su
This contract involves the supply of heart valves specifically designed for younger patients, along with additional accessories necessary for performing valve implantation procedures. The total value of the contract is approximately €4,390,800. The procurement is being conducted by the Wielospecjali
This contract involves the supply of immunoglobulin medicinal products. These products are required for use within the framework of the B.67 drug program, as well as for treating neurological and rheumatic conditions outside of this program. The total value of the contract is approximately €10,393,2
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
